Adani Ports, Bosch, Divi’s Labs, Marico, Welspun Living Hit Record Highs

Fresh Record Highs Reflect Different Drivers Across Indian Stocks

New peaks for a diverse group of companies highlight how company-specific developments are shaping investor interest.

A broad list, but not one common story

Adani Ports and Special Economic Zone (APSEZ), Bosch, Marico, Emcure Pharmaceuticals, Welspun Living, Anand Rathi Wealth Management and Divi’s Laboratories set all-time highs. Indian Hotels Company, PVR Inox and Zydus Lifesciences reached 52-week highs. The stocks gained as much as 10% on the BSE during the session.

The range of companies involved suggests investors were responding to individual business or corporate developments, not just one shared market theme. A record price can reflect changing expectations, but by itself does not establish whether a stock is attractively valued. The catalysts and the earnings assumptions behind them remain important.

APSEZ combines expansion plans with strong relative performance

APSEZ rose 3% intraday to a record ₹1,921, surpassing its previous high of ₹1,891.80. The stock had gained 31% in calendar 2026, compared with a 9% decline in the BSE Sensex, according to the supplied data. That relative outperformance raises the importance of whether operating growth can support expectations embedded in the share price.

Motilal Oswal Financial Services cited steady July-September 2026 performance, growth in international port operations including Colombo, and the consolidation of NQXT from Q4FY26. It expects cargo volumes to grow 14% over FY26-28 and forecasts revenue, EBITDA and profit after tax compound annual growth of 17%, 18% and 21%, respectively. The brokerage retained a Buy rating and a ₹2,130 target, based on 17 times FY28 estimated EV/EBITDA. These are analyst estimates, not assured outcomes; capacity additions and logistics expansion must translate into the projected growth.

Bosch’s proposed actions await a board decision

Bosch climbed 3% to ₹51,249.85 and gained 9% over three trading days after announcing that its board would consider a stock split and bonus issue at its November 6 meeting. The proposals are under consideration and should not be treated as approved. A split changes the number and face value of shares, while a bonus issue distributes additional shares; neither, on its own, changes the underlying business value.

Bosch is also scheduled to consider its September-quarter and half-year results at the meeting. Those operating numbers may offer investors a more direct way to assess business performance than the proposed share actions. The stock has risen 79% since March 30, making expectations and execution relevant considerations alongside any board decision.

Marico’s margin recovery is central to its outlook

Marico gained 3% to ₹895.25, extending a two-session rally in which it rose 12%. In H1FY27, EBITDA increased 26% year on year to ₹1,528 crore, while the EBITDA margin expanded 133 basis points to 19.5%. A 297-basis-point improvement in gross margin supported the expansion; copra prices were 30% below their high, helping offset inflation in other inputs.

Management raised its consolidated EBITDA growth guidance to the mid-20s and expects continued margin improvement. ICICI Securities upgraded its recommendation to Buy and set a ₹1,040 target, citing growth in premium personal care and food. Its assessment also depends on sustained growth and margins, so investors may want to track whether recent input-cost relief persists.

Key Highlights

• Seven BSE 500 stocks reached all-time highs; three others touched 52-week highs.
• APSEZ’s record came alongside forecasts for cargo and earnings growth, as well as strong recent relative performance.
• Bosch’s board is set to consider a split and bonus issue; neither proposal is yet confirmed.
• Marico’s H1FY27 margin expansion and higher growth guidance supported investor interest.
• Record prices do not remove valuation or execution risks; the company-specific outlook remains key.

Investor Note: Treat the new highs as a prompt to examine each company’s earnings drivers, outlook and valuation, rather than as a standalone reason to buy. Brokerage targets and management expectations are not guarantees of future returns.